| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN)
DFFN Technical Analysis
5
| As on 18th Oct 2023 DFFN STOCK Price closed @ 9.25 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.31 & Strong Buy for SHORT-TERM with Stoploss of 7.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DFFNSTOCK Price
| Open | 8.99 | Change | Price | % |
| High | 9.26 | 1 Day | 0.58 | 6.69 |
| Low | 8.99 | 1 Week | 1.87 | 25.34 |
| Close | 9.25 | 1 Month | 4.73 | 104.65 |
| Volume | 7153 | 1 Year | 3.59 | 63.43 |
| 52 Week High 8.38 | 52 Week Low 2.80 | ||||
NASDAQ USA Most Active Stocks
| GNLN | 0.02 | 100.00% |
| HCTI | 0.03 | 200.00% |
| AMRS | 0.14 | 100.00% |
| NCNA | 0.15 | -6.25% |
| NVDA | 145.00 | 1.52% |
| LMDX | 0.02 | 0.00% |
| TSLA | 319.11 | -2.24% |
| AKTS | 0.04 | 0.00% |
| PLUG | 1.30 | -5.80% |
| RSLS | 3.11 | 35.81% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DFFN Daily Charts |
DFFN Intraday Charts |
Whats New @ Bazaartrend |
DFFN Free Analysis |
|
|
DFFN Important Levels Intraday
| RESISTANCE | 9.77 |
| RESISTANCE | 9.60 |
| RESISTANCE | 9.50 |
| RESISTANCE | 9.40 |
| SUPPORT | 9.10 |
| SUPPORT | 9.00 |
| SUPPORT | 8.90 |
| SUPPORT | 8.73 |
DFFN Forecast June 2025
| 4th UP Forecast | 13.72 |
| 3rd UP Forecast | 12.29 |
| 2nd UP Forecast | 11.4 |
| 1st UP Forecast | 10.51 |
| 1st DOWN Forecast | 7.99 |
| 2nd DOWN Forecast | 7.1 |
| 3rd DOWN Forecast | 6.21 |
| 4th DOWN Forecast | 4.78 |
DFFN Weekly Forecast
| 4th UP Forecast | 13.47 |
| 3rd UP Forecast | 12.12 |
| 2nd UP Forecast | 11.28 |
| 1st UP Forecast | 10.44 |
| 1st DOWN Forecast | 8.06 |
| 2nd DOWN Forecast | 7.22 |
| 3rd DOWN Forecast | 6.38 |
| 4th DOWN Forecast | 5.03 |
DFFN Forecast2025
| 4th UP Forecast | 31.62 |
| 3rd UP Forecast | 24.45 |
| 2nd UP Forecast | 20.01 |
| 1st UP Forecast | 15.58 |
| 1st DOWN Forecast | 2.92 |
| 2nd DOWN Forecast | -1.51 |
| 3rd DOWN Forecast | -5.95 |
| 4th DOWN Forecast | -13.12 |
Diffusion Pharmaceuticals Inc ( NASDAQ USA Symbol : DFFN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DFFN Business Profile
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Address: 1317 Carlton Avenue, Charlottesville, VA, United States, 22902
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service